Toripalimab Combined With Definitive CCRT for LACC Patients

Clinical trial NCT06256224 · RECRUITING

Trial details

NCT number: NCT06256224
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cervical Cancer Chemoradiotherapy Immunotherapy

Start date: 2024-02-02
Primary completion: 2028-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.